Jane Street’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-12,200
| Closed | -$46K | – | 4177 |
|
2018
Q2 | $46K | Sell |
12,200
-2,372
| -16% | -$8.94K | ﹤0.01% | 3130 |
|
2018
Q1 | $60K | Buy |
+14,572
| New | +$60K | ﹤0.01% | 2974 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 3714 |
|
2017
Q2 | – | Sell |
-22,848
| Closed | -$141K | – | 3471 |
|
2017
Q1 | $141K | Buy |
+22,848
| New | +$141K | ﹤0.01% | 2596 |
|
2016
Q4 | – | Sell |
-28,511
| Closed | -$151K | – | 3296 |
|
2016
Q3 | $151K | Sell |
28,511
-17,238
| -38% | -$91.3K | ﹤0.01% | 2564 |
|
2016
Q2 | $303K | Sell |
45,749
-40,396
| -47% | -$268K | ﹤0.01% | 2079 |
|
2016
Q1 | $402K | Buy |
86,145
+20,023
| +30% | +$93.4K | ﹤0.01% | 1724 |
|
2015
Q4 | $334K | Sell |
66,122
-23,154
| -26% | -$117K | ﹤0.01% | 1890 |
|
2015
Q3 | $314K | Buy |
89,276
+66,024
| +284% | +$232K | ﹤0.01% | 1877 |
|
2015
Q2 | $232K | Buy |
+23,252
| New | +$232K | ﹤0.01% | 2107 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 2653 |
|
2014
Q4 | – | Sell |
-24,969
| Closed | -$343K | – | 2638 |
|
2014
Q3 | $343K | Buy |
+24,969
| New | +$343K | ﹤0.01% | 1475 |
|
2014
Q2 | – | Sell |
-136,516
| Closed | -$2.33M | – | 3063 |
|
2014
Q1 | $2.33M | Buy |
+136,516
| New | +$2.33M | 0.03% | 369 |
|